Isarna Therapeutics

 

Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to fight cancer and to effectively treat ophthalmic and fibrotic diseases. We are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.

More info…

AAA